|
Volumn 52, Issue 1, 1995, Pages 61-69
|
Gabapentin and lamotrigine: Novel antiepileptic drugs
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ALUMINUM MAGNESIUM HYDROXIDE;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
CIMETIDINE;
CREATININE;
GABAPENTIN;
GLUCURONIC ACID;
GLUTAMIC ACID;
LAMOTRIGINE;
LIVER ENZYME;
MICROSOME ENZYME;
NORETHISTERONE;
ORAL CONTRACEPTIVE AGENT;
PARACETAMOL;
PENTETRAZOLE;
PHENOBARBITAL;
PHENYTOIN;
PRIMIDONE;
PROBENECID;
SEROTONIN;
SODIUM;
VALPROIC ACID;
AREA UNDER THE CURVE;
ATAXIA;
BLOOD BRAIN BARRIER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIPLOPIA;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG PROTEIN BINDING;
EPILEPSY;
FOCAL EPILEPSY;
GASTROINTESTINAL SYMPTOM;
GRAND MAL SEIZURE;
HEADACHE;
HUMAN;
MULTICENTER STUDY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
REVIEW;
VERTIGO;
|
EID: 0028935599
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/52.1.61 Document Type: Review |
Times cited : (16)
|
References (0)
|